Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Exchange Rate Effect (2023 - 2025)

Neurocrine Biosciences' Exchange Rate Effect history spans 3 years, with the latest figure at -$200000.0 for Q3 2025.

  • For Q3 2025, Exchange Rate Effect fell 166.67% year-over-year to -$200000.0; the TTM value through Dec 2025 reached -$200000.0, changed N/A, while the annual FY2023 figure was $300000.0, 123.08% up from the prior year.
  • Exchange Rate Effect reached -$200000.0 in Q3 2025 per NBIX's latest filing, up from -$300000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $300000.0 in Q4 2023 to a low of -$300000.0 in Q4 2024.
  • Average Exchange Rate Effect over 3 years is $25000.0, with a median of $50000.0 recorded in 2023.
  • Peak YoY movement for Exchange Rate Effect: plummeted 200.0% in 2024, then crashed 166.67% in 2025.
  • A 3-year view of Exchange Rate Effect shows it stood at $300000.0 in 2023, then tumbled by 200.0% to -$300000.0 in 2024, then soared by 33.33% to -$200000.0 in 2025.
  • Per Business Quant, the three most recent readings for NBIX's Exchange Rate Effect are -$200000.0 (Q3 2025), -$300000.0 (Q4 2024), and $300000.0 (Q3 2024).